Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M De Antonio Cuscó"'
Autor:
J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, E. Colominas-González, S. Luque, M. Fuster-Esteva, L. Domingo, M. Sala, X. Duran, S. Grau, O. Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection
Externí odkaz:
https://doaj.org/article/d8c28ac897c1429aa94415c9d16ffb26
Autor:
Hernando Knobel, Olivia Ferrández, A Guelar, C Rodríguez Caba, S Castañeda Espinosa, Santiago Grau, M E Molas, N Carballo Martínez, Sonia Luque, M De Antonio Cuscó
Publikováno v:
Revista Española de Quimioterapia
Background. The health crisis due to the COVID-19 pandemic is a challenge in the dispensing of outpatient hospital medication (OHM). Models of Antiretroviral Therapy (ART) based on community pharmacy support (ARTCP) have proven to be successful. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05e476ad4e56d1ba4ab6fe196459754
https://doi.org/10.37201/req/055.2021
https://doi.org/10.37201/req/055.2021
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E Gonzalez Colominas, M De Antonio Cuscó, M Masip Torne, M Martin, G Cardona, M Comas, MA Roch, B López, FI Torres, A Retamero, P Luque
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17d97c4c231e0318599f2b7d2264935
https://doi.org/10.1136/ejhpharm-2022-eahp.412
https://doi.org/10.1136/ejhpharm-2022-eahp.412
Autor:
X Fernández-Sala, L. Comella-Anaya, Jaime Barceló-Vidal, E González-Colominas, C. López-Mula, Olivia Ferrández, P Acin, Sonia Luque, Daniel Echeverría-Esnal, N Carballo, M De Antonio-Cuscó
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Drug related problems (DRP) are common among hospitalised patients. During the COVID-19 pandemic, the number of inpatients increased and the pattern of drug use was varied which could lead to a higher number of potential DRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aada10311aa6ae7a06e527352222783
https://doi.org/10.1136/ejhpharm-2021-eahpconf.216
https://doi.org/10.1136/ejhpharm-2021-eahpconf.216
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N Carballo, Santiago Grau, M De Antonio-Cuscó, Olivia Ferrández, Jaime Barceló-Vidal, E González-Colominas, X Fernandez Sala, E. Salas
Publikováno v:
Eur J Hosp Pharm
Background Hospitals cannot include all marketed drugs in their formularies. Those drugs not included in the formulary (NFD) need an alternative drug available (ALT) in order to cover all patient requirements. Purpose To assess the prevalence of NFD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e7b9d9440c19e9308b2ffafd890a4b
https://europepmc.org/articles/PMC7535382/
https://europepmc.org/articles/PMC7535382/
Publikováno v:
Pharmacokinetics and pharmacodynamics.
Background Continuous vancomycin infusion (CVI) is frequently used to achieve therapeutic levels (15–25 mg/L) in patients in whom, related to their physiological characteristics (young, obese or critical patient), intermittent infusion (II) would n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eddf545e893495638bbb3731355d2f4b
https://doi.org/10.1136/ejhpharm-2017-000640.441
https://doi.org/10.1136/ejhpharm-2017-000640.441
Autor:
E González-Colominas, M De Antonio-Cuscó, Inés Monge-Escartín, Olivia Ferrández, Hernando Knobel, Sonia Luque, E. Salas
Publikováno v:
Clinical pharmacy.
Background Integrase inhibitors (INSTIs) are recommended as firstline antiretroviral treatment (ART) in HIV patients. However, several factors such as toxicity, virological failure or a low adherence can lead to a switch of ART. Purpose To assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e869e5ef36e767e5a0f49dd30ee5ab
https://doi.org/10.1136/ejhpharm-2017-000640.178
https://doi.org/10.1136/ejhpharm-2017-000640.178